All News
Eat, Drink, and Be Wary
(MedPage Today) -- In the last year, Claire Panosian Dunavan, MD, wrote two op-eds for MedPage Today pertaining to dangerous foodborne disease outbreaks.
Read MoreMedicare Will Cover Blood Tests to Monitor for Transplant Rejection, for Now
(MedPage Today) -- In August, we reported on the decision by the Centers for Medicare & Medicaid Services (CMS) to not pursue a proposed Medicare policy that would have restricted coverage of a b
Read MoreMost Americans blame insurance profits and denials alongside the killer in UHC CEO death, poll finds
About 7 in 10 adults say denials for health care coverage, or insurer profits, bear at least "a moderate amount" of responsibility for Thompson's death.
Read MoreMetastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'
(MedPage Today) -- Metastatic cancer "thrivers" offer hope and inspiration to others with cancer.
Read MoreRevealed: 1.5m children in England studying in unfit school buildings
Underinvestment has led to crumbling infrastructure in schools, hospitals and courts, Guardian study shows‘Our school has been homeless for two years’More than 1.
Read MoreTransitioning From Pediatric to Adult Care for Beta-Thalassemia
(MedPage Today) -- Patients with beta-thalassemia major (also known as Cooley's anemia) have a reduction or absence of beta protein in their hemoglobin, resulting in severe anemia, which requires reg
Read MoreStem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia
(MedPage Today) -- While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell transplantation (HSCT) remains the only widely accessible curative
Read MoreMezigdomide Combinations Show Promise in Multiple Myeloma
(MedPage Today) -- The phase I/II CA057-003 trial presented at the American Society of Hematology annual meeting showed promising results with novel mezigdomide-based combinations in relapsed or refr
Read MoreTesting Elacestrant With Other Targeted Drugs for Metastatic Breast Cancer
(MedPage Today) -- Findings from the phase Ib/II ELEVATE trial presented at the San Antonio Breast Cancer Symposium demonstrated the potential of the oral selective estrogen receptor degrader elacest
Read MoreSTAT+: ‘There is a lot more anxiety here’: Scientists brace for shake-ups to health funding under Trump
Scientists are uneasy about NIH research funding priorities and Trump's pick to lead the NIH, Jay Bhattacharya
Read More